investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

$AGLE: Aeglea BioTherapeutics, Inc. - Common Stock

+ Medicine, Disease: Metabolic disorders



Clear duplicates of prices



2024-03-29

AGLE 2024-03-29 21:47:38
S-1/A Sec report https://www.sec.gov/Archives/edgar/data/1855485/000149315224012083/0001493152-24-012083-index.htm
S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
2024-04-01

AGLE 2024-04-01 09:00:29
8-K Sec report https://www.sec.gov/Archives/edgar/data/1855485/000149315224012176/0001493152-24-012176-index.htm
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
2024-04-02

AGLE 2024-04-02 17:29:35
S-1/A Sec report https://www.sec.gov/Archives/edgar/data/1855485/000149315224012869/0001493152-24-012869-index.htm
S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
2024-04-08

AGLE 2024-04-08 16:40:11
S-1/A Sec report https://www.sec.gov/Archives/edgar/data/1855485/000149315224013794/0001493152-24-013794-index.htm
S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
2024-04-15

AGLE 2024-04-15 06:31:50
S-1/A Sec report https://www.sec.gov/Archives/edgar/data/1855485/000149315224014529/0001493152-24-014529-index.htm
S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
2024-04-18

AGLE 2024-04-18 17:00:15
8-K Sec report https://www.sec.gov/Archives/edgar/data/1855485/000149315224015220/0001493152-24-015220-index.htm
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
2024-04-19

AGLE 2024-04-19 17:20:14
8-K Sec report https://www.sec.gov/Archives/edgar/data/1855485/000149315224015390/0001493152-24-015390-index.htm
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
AGLE 2024-04-19 17:25:52
8-K Sec report https://www.sec.gov/Archives/edgar/data/1855485/000149315224015397/0001493152-24-015397-index.htm
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.